Stockscreener 앱 받기
5.65
0.10%
0.0057
전일 마감가:
$5.6443
열려 있는:
$4.99
하루 거래량:
8,060
Relative Volume:
1.13
시가총액:
$93.57M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+14.11%
1개월 성능:
-10.03%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$4.99
$5.65
1주일 범위
$4.7237
$5.65
52주 변동 폭
$4.7237
$6.85
Bioharvest Sciences Inc Stock (BHST) Company Profile
BHST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHST
Bioharvest Sciences Inc
|
5.65 | 93.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.52 | 125.39B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
721.88 | 79.10B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
669.77 | 40.58B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
275.60 | 35.43B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
122.33 | 29.34B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bioharvest Sciences Inc Stock (BHST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-18 | 개시 | Maxim Group | Buy |
Bioharvest Sciences Inc 주식(BHST)의 최신 뉴스
When Will BioHarvest Sciences Inc. (CSE:BHSC) Become Profitable? - Simply Wall St
BioHarvest Sciences reports material change - Investing.com India
BioHarvest Sciences Appoints Sharon Malka to Board of Directors - TipRanks
BioHarvest Sciences reports material change By Investing.com - Investing.com UK
BioHarvest Sciences appoints veteran technology leader to board of directors - Proactive Investors USA
BioHarvest Announces Appointment of Sharon Malka to Board of Directors - Newsfile
Bioharvest Sciences Inc. Appoints Sharon Malka as Independent Director -January 22, 2025 at 08:34 am EST - Marketscreener.com
OTC Markets Group Announces Quarterly Index Performance and Rebalancing - GlobeNewswire Inc.
BioHarvest Sciences Strengthens Board with Healthcare Industry Veteran Sharon Malka - StockTitan
BioHarvest Sciences positioned for ‘legacy year’ in 2025, building on momentum with new innovations and strategic collaborations - Proactive Investors USA
BioHarvest Sciences doubles VINIA business, eyes growth By Investing.com - Investing.com Australia
CSE Bulletin: NV Issuer DesignationBioHarvest Sciences Inc. (BHSC) - Newsfile
BioHarvest Sciences CEO reflects on transformative 2024, outlines vision for future growth - Proactive Investors UK
BioHarvest Sciences Unveils Strategic Growth Initiatives with New CDMO Division - TipRanks
BioHarvest Sciences doubles VINIA business, eyes growth - Investing.com
BioHarvest Issues Shareholder Letter and Provides Corporate Update - Yahoo Finance
BioHarvest Sciences (NASDAQ:BHST) Earns Buy Rating from Analysts at Maxim Group - Defense World
Maxim Group sets Buy rating on BioHarvest Sciences shares, cites robust growth - Investing.com India
BioHarvest Sciences (NASDAQ:BHST) Now Covered by Maxim Group - MarketBeat
BioHarvest Sciences CEO discusses Tate & Lyle partnershipICYMI - Proactive Investors USA
Clean the SkyBotanical Sweetener Partnerships - Trend Hunter
BioHarvest Sciences shares keep buy rating, partnership drives optimism By Investing.com - Investing.com South Africa
BioHarvest Sciences shares keep buy rating, partnership drives optimism - Investing.com India
Tate & Lyle and BioHarvest collaboration to pioneer next gen plant-based ingredients - Food and Drink Technology
BioHarvest Sciences Partners with Tate & Lyle to Develop Sustainable Plant-Based Sweeteners - Proactive Investors USA
BioHarvest Sciences partners with Tate & Lyle to advance plant-based sweeteners - Proactive Investors UK
EXCLUSIVE: BioHarvest Collaborate With Tate & Lyle To Develop Proprietary Plant-Based Molecules - AOL
Tate & Lyle and BioHarvest Announce Partnership to Drive the Future of Ingredients Through Botanical Synthesis Technology - Newsfile
Tate & Lyle Partners with BioHarvest Sciences to Revolutionize Plant-Based Sweeteners Using Breakthrough Technology - StockTitan
BHST News Today | Why did BioHarvest Sciences stock go up today? - MarketBeat
HC Wainwright Initiates Coverage on BioHarvest Sciences (NASDAQ:BHST) - Defense World
CNVCF (BioHarvest Sciences) GF Value Rank : 2 (As of Nov. 30, 2024) - GuruFocus.com
BioHarvest Sciences expands VINIA product line with launch of SuperFood Infused Teas - Proactive Investors Australia
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
BioHarvest Sciences Inc. (BHST) Reports Q3 Loss, Misses Revenue Estimates - MSN
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Expansion - GuruFocus.com
BioHarvest Sciences Inc (CNVCF) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance
BioHarvest reports strong response from VINIA Superfood Coffee - Comunicaffe
BioHarvest Launches VINIA SuperFood Functional Tea Line - Sault This Week
Bioharvest Sciences Inc (BHST) 재무 분석
Bioharvest Sciences Inc (BHST)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.57%
1.13%
자본화:
|
볼륨(24시간):